Investing 101: Analyzing S. Muoio & Co. LLC Q2 2022 vs. Q3 2022 13F Holdings

For investors, analyzing institutional filings is an important part of the investment process. Tracking changes in institutional holdings is key to identifying potential investment opportunities or indicating areas of concern. In this article, we will be analyzing S. Muoio & Co. LLC's Q2 2022 vs. Q3 2022 13F Holdings with a particular focus on changes made during the quarter.

S. Muoio & Co. LLC is a New York-based institutional investment manager. Its investment approach targets long-term value creation in individual equities, seeking investment opportunities that are typically driven by change. The company focuses on a broad number of sectors, but the top two sectors in which it invests are Information Technology and Healthcare.

During Q2 2022, S. Muoio & Co. LLC made several changes to their holdings, including:

- Adding to their Citrix Systems holdings. In Q2 2022, S. Muoio & Co. LLC held 33,000 shares of Citrix Systems, worth $3.2 million. By the end of Q3 2022, the investment manager's holdings increased to 45,150 shares, valued at $4.7 million.

- Adding Biohaven Pharmaceutical Holdings. S. Muoio & Co. LLC added to their Biohaven Pharmaceutical Holdings holdings during Q3 2022, purchasing 5,480 shares, valued at $2.9 million. The investment manager now holds a total of 18,980 shares, worth $2.8 million.

- Increasing their holdings of Tower Semiconductor Ltd. S. Muoio & Co. LLC's holdings in Tower Semiconductor Ltd. increased during Q3 2022 to 33,000 shares, valued at $1.5 million. This represents an increase from the Q2 holdings of 27,000 shares, worth $1.2 million.

- Selling their MagnaChip Semiconductor Corp. shares. In Q2 2022, S. Muoio & Co. LLC held 119,173 shares of MagnaChip Semiconductor Corp. However, by Q3 2022, the investment manager had divested all of their shares in the company.

- Exiting the Global Blood Therapeutics Inc. position. S. Muoio & Co. LLC had no holdings in Global Blood Therapeutics Inc. in Q2 2022. However, during Q3 2022, they purchased 40,710 shares, valued at $2.8 million. By the end of the quarter, S. Muoio & Co. LLC had liquidated their entire position in the company.

- Adding to their Sinclair Broadcast Group Inc. holdings. S. Muoio & Co. LLC added to their Sinclair Broadcast Group Inc. holdings during Q3 2022, purchasing an additional 2,600 shares, valued at $0.2 million. The investment manager now holds a total of 36,517 shares, worth $0.7 million.

Overall, S. Muoio & Co. LLC's Q2 2022 vs. Q3 2022 13F Holdings revealed that the investment manager made several changes to their holdings over the quarter, with the most notable changes including adding to their Citrix Systems, Biohaven Pharmaceutical Holdings, and Sinclair Broadcast Group Inc. positions, increasing their holdings in Tower Semiconductor Ltd., and exiting their MagnaChip Semiconductor Corp. and Global Blood Therapeutics Inc. positions. As an individual investor, tracking institutional holdings can be an essential tool for identifying potential investment opportunities or areas of concern.